NEW DRUG APPROVAL PROCESS FOR RADIOPHARMACEUTICALS

被引：0

|

作者：

SHEININ, EB ^{[1
]}

KISHORE, R ^{[1
]}

机构：

[1] US FDA,ROCKVILLE,MD 20857

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1990年 / 200卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：157 / NUCL

相关论文

共 50 条

[1] THE FRENCH PROCEDURE FOR GRANTING NEW DRUG APPROVAL FOR RADIOPHARMACEUTICALS
VERAIN, A
NUCLEAR MEDICINE AND BIOLOGY, 1986, 13 (02): : 215 - 220
[2] Food and Drug Administration Requirements for Testing and Approval of New Radiopharmaceuticals
Harapanhalli, Ravi S.
SEMINARS IN NUCLEAR MEDICINE, 2010, 40 (05) : 364 - 384
[3] Reform of the new drug approval process
VanHuysen, MP
ADMINISTRATIVE LAW REVIEW, 1997, 49 (02) : 477 - 499
[4] MITOXANTRONE AND THE NEW DRUG APPROVAL PROCESS
ABELOFF, MD
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (05) : 551 - 553
[5] New drug approval process in Japan
Hayakawa, T
CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (03) : 307 - 311
[6] THE FDA NEW DRUG APPROVAL PROCESS
GIFFORD, RW
CONNECTICUT MEDICINE, 1980, 44 (05) : 309 - 311
[7] Food and Drug Administration process for development and approval of drugs and radiopharmaceuticals: Treatments in urologic oncology
Ning, Yang-Min
Maher, V. Ellen
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (03) : 137 - 142
[8] NEW DRUG APPROVAL PROCESS UNDER SCRUTINY
ROSS, C
LANCET, 1994, 344 (8929): : 1075 - 1076
[9] THE NEW DRUG APPROVAL PROCESS - CHANGES AND IMPACTS
PESKOE, MP
FOOD AND DRUG LAW JOURNAL, 1986, 41 (02): : 195 - 200
[10] User fees and the new drug approval process.
Kaitin, KI
Powers, P
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII2 - PII2

← 1 2 3 4 5 →